289 related articles for article (PubMed ID: 22156587)
1. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race.
Hayes J; Kalantar-Zadeh K; Lu JL; Turban S; Anderson JE; Kovesdy CP
Nephron Clin Pract; 2012; 120(1):c8-16. PubMed ID: 22156587
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
[TBL] [Abstract][Full Text] [Related]
3. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
[TBL] [Abstract][Full Text] [Related]
4. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
[TBL] [Abstract][Full Text] [Related]
5. Outcomes associated with race in males with nondialysis-dependent chronic kidney disease.
Kovesdy CP; Anderson JE; Derose SF; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2009 May; 4(5):973-8. PubMed ID: 19369403
[TBL] [Abstract][Full Text] [Related]
6. Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
Gilligan S; Raphael KL
Adv Chronic Kidney Dis; 2017 Sep; 24(5):315-318. PubMed ID: 29031358
[TBL] [Abstract][Full Text] [Related]
7. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
[TBL] [Abstract][Full Text] [Related]
8. Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.
Dashputre AA; Sumida K; Thomas F; Gatwood J; Akbilgic O; Potukuchi PK; Obi Y; Molnar MZ; Streja E; Kalantar Zadeh K; Kovesdy CP
Am J Nephrol; 2021; 52(7):539-547. PubMed ID: 34289468
[TBL] [Abstract][Full Text] [Related]
9. Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.
Goncalves FA; de Jesus JS; Cordeiro L; Piraciaba MCT; de Araujo LKRP; Steller Wagner Martins C; Dalboni MA; Pereira BJ; Silva BC; Moysés RMA; Abensur H; Elias RM
Int Urol Nephrol; 2020 Feb; 52(2):393-398. PubMed ID: 32016907
[TBL] [Abstract][Full Text] [Related]
10. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
[TBL] [Abstract][Full Text] [Related]
11. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
[TBL] [Abstract][Full Text] [Related]
12. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME;
Eur Heart J; 2018 May; 39(17):1535-1542. PubMed ID: 29554312
[TBL] [Abstract][Full Text] [Related]
13. Hyperkalemia in chronic peritoneal dialysis patients.
Elliott AB; Soliman KMM; Ullian ME
Ren Fail; 2022 Dec; 44(1):217-223. PubMed ID: 35166182
[No Abstract] [Full Text] [Related]
14. [The prevalence, influencing factors and prognosis of abnormal serum potassium levels in patients with chronic kidney disease].
Wang F; Yang C; Gao BX; Zhang LX; Zhao MH; Wang JW
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3459-3465. PubMed ID: 34775702
[No Abstract] [Full Text] [Related]
15. [Potassium in renal disease].
Lenz T; Becker B; Bergner R
Med Klin (Munich); 2004 Jul; 99(7):355-61. PubMed ID: 15322714
[TBL] [Abstract][Full Text] [Related]
16. Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population.
Kieneker LM; Eisenga MF; Joosten MM; de Boer RA; Gansevoort RT; Kootstra-Ros JE; Navis G; Bakker SJ
PLoS One; 2017; 12(3):e0174686. PubMed ID: 28346526
[TBL] [Abstract][Full Text] [Related]
17. Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations.
Peralta CA; Lin F; Shlipak MG; Siscovick D; Lewis C; Jacobs DR; Bibbins-Domingo K
Nephrol Dial Transplant; 2010 Dec; 25(12):3934-9. PubMed ID: 20519233
[TBL] [Abstract][Full Text] [Related]
18. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
Nilsson E; Gasparini A; Ärnlöv J; Xu H; Henriksson KM; Coresh J; Grams ME; Carrero JJ
Int J Cardiol; 2017 Oct; 245():277-284. PubMed ID: 28735756
[TBL] [Abstract][Full Text] [Related]
19. Predictors of hyperkalemia and death in patients with cardiac and renal disease.
Jain N; Kotla S; Little BB; Weideman RA; Brilakis ES; Reilly RF; Banerjee S
Am J Cardiol; 2012 May; 109(10):1510-3. PubMed ID: 22342847
[TBL] [Abstract][Full Text] [Related]
20. Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
Desai AS; Liu J; Pfeffer MA; Claggett B; Fleg J; Lewis EF; McKinlay S; O'Meara E; Shah SJ; Sweitzer NK; Solomon S; Pitt B
J Card Fail; 2018 May; 24(5):313-320. PubMed ID: 29572190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
